Addressing Challenges in Developing Treatments for Inherited Retinal Diseases: Recommendations From the Third Monaciano Symposium
Year: 2025
Type: review
Abstract: Over the past decade, efforts focused on developing genetic therapies for inherited retinal diseases have advanced steadily to clinical trials and the development of a treatment, fueling optimism for the potential of precision medicines to provide safe and effective therapies for these rare conditions. Although several ongoing programs remain poised for success, numerous challenges have negatively impacted the ability to obtain regulatory approvals. The present position paper briefly summarizes recent advances and challenges in developing therapeutics for inherited retinal diseases, and presents a set of recommendations for moving the field forward. The priorities identified are discussed in terms of progress made and future needs, focusing on areas including patient support, disease mechanisms, outcome measures, and therapy approvals. A key point is the potential value of restructuring collaborative interactions into broadly resourced enterprises that are comprehensive in scope across critical areas of science, business, and medicine.
DOI: 10.1167/tvst.14.8.37
Authors: Debra A. Thompson, K. Thiran Jayasundera, Oleg Alekseev, Robin R. Ali, Alessia Amato, Vadim Y. Arshavsky, Isabelle S. Audo, Alberto Auricchio, James W. B. Bainbridge, Eyal Banin, Cagri G. Besirli, David G. Birch, Kari E. Branham, Artur V. Cideciyan, Stephen P. Daiger, Jacque L. Duncan, Abigail T. Fahim, John G. Flannery, Roberto Gattegna, John R. Heckenlively, Elise Héon, Alessandro Iannaccone, Naheed W. Khan, Samer Khateb, Henry J. Klassen, Bart P. Leroy, Dario Marangoni, Michel Michaelides, David C. Musch, Mark E. Pennesi, Simon M. Petersen-Jones, Eric A. Pierce, Rajesh C. Rao, José-Alain Sahel, Paul A. Sieving, Enrica Strettoi, Cameron R. Strong, Thomas J. Wubben, Paul Yang, David N. Zacks
Institutions: University of Michigan, Michigan Medicine, Duke University, Duke Medical Center, King's College London, Bambino Gesù Children's Hospital, Centre National de la Recherche Scientifique, Institut de la Vision, Inserm, Centre hospitalier national d'ophtalmologie des Quinze-Vingts, Sorbonne Université, Telethon Institute Of Genetics And Medicine, University College London, Hebrew University of Jerusalem, Hadassah Medical Center, Retina Foundation of the Southwest, University of Pennsylvania, The University of Texas Health Science Center at Houston, University of California, San Francisco, University of California, Berkeley, Ospedale Israelitico, Hospital for Sick Children, University of North Carolina at Chapel Hill, University of North Carolina Health Care, Astellas Pharma (United States), University of California, Irvine, Children's Hospital of Philadelphia, Ghent University Hospital, Ghent University, University of Trieste, Moorfields Eye Hospital, Oregon Health & Science University, Michigan State University, Massachusetts Eye and Ear Infirmary, Harvard University, UPMC Health System, Fondation Ophtalmologique Adolphe de Rothschild, University of Pittsburgh Medical Center, University of California Davis Medical Center, University of California, Davis, Neuroscience Institute, National Research Council, University of Washington
Language: English
Subfield: Ophthalmology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $1,850
OpenAlex ID: W4413745895
